Waardenburg Syndrome Panel
Use
This test is intended for individuals who have relevant features or a clinical or suspected diagnosis of Waardenburg syndrome. It aims to provide diagnostic clarity by analyzing the genetic components associated with this condition through an 8-gene panel.
Special Instructions
The test is available with STAT option which accelerates the process, delivering results in 7-16 days. New York state approval allows ordering within New York. Compatibility with specific analyte platforms like Exome or Genome is necessary for processing.
Limitations
The test has not been cleared or approved by the US Food and Drug Administration (FDA). This implies limitations in regulatory review which could affect the clinical application. Furthermore, the panel might not detect all genetic variations associated with Waardenburg syndrome, particularly if they fall outside the included gene set.
New York Approved
Methodology
NGS
Biomarkers
Result Turnaround Time
14-21 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided